Navigation Links
Leading Cardiologist Stands By Use of Dietary Supplement Niacin in the Form of Nicotinic Acid to Support Heart Health
Date:8/7/2013

MAPLE GROVE, Minn., Aug. 7, 2013  /PRNewswire/ -- There has been a great deal of media coverage surrounding heart health and niacin, leaving some consumers confused about its benefits, according to leading cardiologist, Dr. Carl Lavie, Medical Director of Cardiac Rehabilitation and Prevention at the John Ochsner Heart and Vascular Institute, New Orleans, LA.  For cholesterol-conscious consumers who are serious about optimizing heart health, Dr. Lavie stands by his long-term recommendation to use a dietary supplement niacin that contains nicotinic acid, the only form of niacin clinically proven to support healthy good cholesterol and a healthy heart.

"As a cardiologist, I have been recommending dietary supplement niacin in the form of nicotinic acid to my patients for over two decades," said Dr. Lavie. "After years of experience in cardiology and extensive study in the treatment of cholesterol, I am confident in my recommendation of a dietary supplement niacin in the form of nicotinic acid, like Slo-Niacin®, to help maintain healthy good cholesterol. Nicotinic acid is the only form of niacin clinically proven to support healthy good cholesterol and a controlled-release dietary supplement niacin, like Slo-Niacin®, ensures the gradual and measured release of nicotinic acid into the body while helping to reduce the likelihood of flushing." 

About Flushing

When taking dietary supplement niacin in the form of nicotinic acid, some people, but not all, may experience a side effect called niacin flushing. Flushing is a temporary vasodilation or widening of blood vessels in the skin. Slo-Niacin® Tablets utilize a unique polygel® controlled-release system that ensures the gradual and measured release of the doctor-recommended form of niacin, nicotinic acid, and is designed to minimize flushing that is sometimes associated with niacin use.

About Slo-Niacin® Tablets

At approximately $16 for one-hundred 500 mg tablets, Slo-Niacin® Tablets are an affordable option to help support a healthy heart. To support individual heart health needs, Slo-Niacin® Tablets are available in three strengths (250 mg, 500 mg, and 750 mg).

Slo-Niacin® Tablets are manufactured by Upsher-Smith Laboratories, Inc., a trusted manufacturer of quality dietary supplement and prescription products since 1919. Slo-Niacin® Tablets are conveniently available at pharmacies and other retailers nationwide, without a prescription. For more information, coupons, and a store locator, visit www.Slo-Niacin.com.

About Upsher-Smith Laboratories, Inc.

Upsher-Smith Laboratories, Inc. is a privately held, U.S.-based company devoted to improving health and advancing wellness since 1919.  Upsher-Smith demonstrates its commitment to meeting the healthcare needs of its customers through developing, producing and marketing consumer and prescription products.  In addition to its strong heritage in generics, Upsher-Smith's branded businesses focus on women's health, dermatology and CNS therapeutic areas.  For additional information, visit http://www.upsher-smith.com.  

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Dr. Lavie consults on behalf of Upsher-Smith Laboratories, Inc.

Sources:

Data on File. Upsher-Smith Laboratories, Inc.; 2013.
Slo-Niacin product information. http://www.slo-niacin.com/about-slo-niacin/directions-for-use. Upsher-Smith
Laboratories, 2011. Accessed July 17, 2013.
Mayo Clinic Web site. http://mayoclinic.com. Accessed July 17, 2013.
NHLBI: National Cholesterol Education Program. http://www.nhlbi.nih.gov/about/ncep. Accessed July 17, 2013.
Harvard Health Lett. 2007; July:7. http://www.health.harvard.edu. Accessed July 17, 2013.
Centers for Disease Control and Prevention, http://www.cdc.gov/cholesterol/facts.htm Accessed July 17, 2013.


'/>"/>
SOURCE Upsher-Smith Laboratories, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
2. Amgen to Acquire Mustafa Nevzat, a Leading Privately Held Turkish Pharmaceutical Company
3. Industry Leading Pharmaceutical News Website in-Pharmatechnologist.com Refocused and Relaunched
4. Remedy Informatics Named "Cool Vendor" in Life Sciences by Leading Technology Analyst Firm
5. PeaceHealth Laboratories New Patent Addresses a Leading Cause of Death: Prescription Drug Abuse
6. Software Pioneer Leaves $10 Million Bequest To Five Leading Non-profits In Health And Drug Policy Reform
7. Leading Pension Annuity Provider Legal & General, Celebrates 175 Years
8. Denton Vacuum Ships Breakthrough Wafer-level Optics Development System to Leading German R&D Organization
9. FMC Corporation Acquires Phytone, Ltd., a Leading European Natural Colors Business
10. Court Preliminarily Deems Millennium Laboratories Press Release Misleading
11. AstraZeneca and Leading Academic Scientists to Collaborate on Alzheimers Disease Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... 27, 2016 Kitov ... focused on late-stage drug development, today announced the ... of pivotal batches required for registration of KIT-302 ... This follows Kitov,s announcement in December ... met its primary efficacy endpoint. "We ...
(Date:5/26/2016)... 2016 TARE (Transarterial Radio-embolization) ... Savings and Overall Decreased Use of Hospital ... international specialist healthcare company, has today announced the ... Meeting of ISPOR (International Society for Pharmacoeconomics and ... (HCC) using yttrium-90 glass microspheres is associated with ...
(Date:5/25/2016)... HILDEN , Deutschland und GERMANTOWN, ... Zusammenarbeit mit Therawis bedient ... Entscheidungen bei Brustkrebs   QIAGEN N.V. ... QIA) gab heute bekannt, eine Lizenz- und Entwicklungsvereinbarung ... prädiktiver Assays für die Onkologie eingegangen zu sein. ...
Breaking Medicine Technology:
(Date:5/28/2016)... ... May 28, 2016 , ... May 26, 2016- In ... Arts Fighting Challenge with theme event of “K Warriors” on June 4, 2016 at ... , The event is sponsored and hosted by Shaolin Institute and sanctioned by ...
(Date:5/27/2016)... , ... May 27, 2016 , ... Two director-level employees ... YWCA Tribute to Women and Industry (TWIN) 2016 honorees. The award recognizes businesswomen ... For this year, Geri Boone, Director of the MLTSS (Managed Long-Term Services and Supports) ...
(Date:5/27/2016)... NY (PRWEB) , ... May 27, 2016 , ... ... casual readers, this installment is bolstered by inspiring human-interest stories, courtesy of awareness-driven ... tech within the industry, from leading advocates, associations and industry leaders such as ...
(Date:5/27/2016)... ... May 27, 2016 , ... ... students studying complementary medicine. Allison Outerbridge is this year’s Life University ... May 18 at the university’s Student Leadership Awards ceremony. , Outerbridge is approaching ...
(Date:5/26/2016)... ... May 26, 2016 , ... Cabot Corporation, Pfizer, ... respirators, according to court documents and SEC filings. A jury has returned ... v. American Optical Corporation, Case No. BC588866, Los Angeles County, California. The jury ...
Breaking Medicine News(10 mins):